34 results
8-K
EX-99.1
IOBT
IO Biotech Inc
8 Jan 24
Regulation FD Disclosure
8:11am
and continuing to expand. *Two of the 24 responding patients progressed before subsequent radiological confirmation (as previously reported in Nature … %
CLINICAL TRIALS | Successful outcomes from phase 1/2 were published in Nature Medicine and drove continued clinical development for 1L melanoma Compelling
8-K
EX-99.2
a5l gjgpp4
7 Aug 23
IO Biotech, Inc. Announces $75 Million Private Placement Financing
8:31am
8-K
EX-10.1
gnm7k8hd8v2pyg4cg8
7 Aug 23
IO Biotech, Inc. Announces $75 Million Private Placement Financing
8:31am
PRE 14A
d86c7nks7go1ztxrqz
14 Apr 23
Preliminary proxy
4:39pm
DEF 14A
r9u78
14 Apr 22
Definitive proxy
4:02pm
10-K
6zerh2ftl4kcn 9o
31 Mar 22
Annual report
5:07pm
8-K
EX-99.1
kz3yg 75x
31 Mar 22
IO Biotech Announces Year-End Results for 2021
4:27pm
10-Q
4uqva9x
17 Dec 21
Quarterly report
4:55pm
8-K
EX-99.1
kto1hiirzjmgxfc wyvn
17 Dec 21
Results of Operations and Financial Condition
4:40pm
8-K
EX-10.1
bz13s63
6 Dec 21
Entry into a Material Definitive Agreement
9:00am
424B4
u9uesp
8 Nov 21
Prospectus supplement with pricing info
5:20pm